Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the therapeutic landscape: Biologics and immunosuppressive therapy in lupus nephritis during pregnancy.

Lupus·2026
Same author

Cardiolipin preserves T<sub>reg</sub> metabolic fitness and immune homeostasis in the gut.

Nature metabolism·2026
Same author

REGEN-COV as the First Line of Defense-A Single-Centre Experience.

Life (Basel, Switzerland)·2026
Same author

Functional Food-Derived Urolithins: Molecular Mechanisms, Health Effects, and Interactomics with Proteins and Extracellular Vesicles.

Molecules (Basel, Switzerland)·2026
Same author

Application of VHH-Immobilized Cryogel-Based Immunoaffinity Chromatography for Isolation of Extracellular Vesicles.

Molecules (Basel, Switzerland)·2025
Same author

Anti-PL-12 and Interstitial Lung Disease as the First Signs of Antisynthetase Syndrome in Patients With Previously Diagnosed Systemic Lupus Erythematosus.

Cureus·2025

Related Experiment Video

Updated: May 8, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.3K

Ceftriaxone-Induced Pancytopenia: A Case Report.

Edin Karisik1, Zorica Stanojevic-Ristic2, Marija Jevtic3

  • 1Department of Internal Medicine, General Hospital Novi Pazar, 36300 Novi Pazar, Serbia.

Hematology Reports
|June 25, 2025
PubMed
Summary

Ceftriaxone, a common antibiotic, can rarely cause pancytopenia (low blood counts). Prompt drug withdrawal and supportive care led to recovery, highlighting the need for vigilance with antibiotic-induced cytopenias.

Keywords:
antibioticsceftriaxonefilgrastimidiosyncrasypancytopenia

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Related Experiment Videos

Last Updated: May 8, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.3K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Area of Science:

  • Hematology
  • Pharmacology
  • Internal Medicine

Background:

  • Cephalosporins are generally considered safe antibiotics.
  • Rarely, serious hematological abnormalities can occur following cephalosporin therapy.
  • This case highlights a potential adverse effect of a widely used antibiotic.

Observation:

  • A 72-year-old female developed pancytopenia after five days of ceftriaxone treatment for a urinary tract infection.
  • Extensive diagnostic workup excluded other causes of cytopenia.
  • Bone marrow aspiration revealed hypocellularity without malignancy; peripheral smear showed no dysplasia or hemolysis.

Findings:

  • Ceftriaxone was identified as the likely cause of drug-induced pancytopenia.
  • Discontinuation of ceftriaxone and administration of granulocyte colony-stimulating factor (G-CSF) resulted in significant clinical improvement.
  • The patient's recovery suggests an idiosyncratic, immune-mediated mechanism.

Implications:

  • Clinicians should maintain a high index of suspicion for drug-induced cytopenias in patients receiving antibiotics.
  • Thorough medication history and exclusion of alternative causes are crucial for diagnosis.
  • Further research into pharmacogenomic screening, particularly involving HLA variants, may identify patients at increased risk for such adverse events.